Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.170
-0.010 (-0.31%)
At close: Mar 6, 2026, 4:00 PM EST
3.155
-0.015 (-0.48%)
After-hours: Mar 6, 2026, 6:47 PM EST
Cabaletta Bio Employees
As of December 31, 2024, Cabaletta Bio had 164 total employees, including 148 full-time and 3 part-time employees. The number of employees increased by 61 or 59.22% compared to the previous year.
Employees
164
Change (1Y)
61
Growth (1Y)
59.22%
Revenue / Employee
n/a
Profits / Employee
-$1,049,821
Market Cap
305.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 172 |
| Nautilus Biotechnology | 124 |
| Silence Therapeutics | 116 |
| C4 Therapeutics | 110 |
| ALX Oncology Holdings | 44 |
| Protara Therapeutics | 33 |
| Avalo Therapeutics | 23 |
| XOMA Royalty | 13 |
CABA News
- 11 days ago - Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 4 weeks ago - Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 5 weeks ago - Cabaletta Bio: Do You Buy With The Insiders? - Seeking Alpha
- 7 weeks ago - Cabaletta Bio Announces 2026 Strategic Priorities - GlobeNewsWire
- 7 weeks ago - IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms - Business Wire
- 3 months ago - Cabaletta Bio, Inc. (CABA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 months ago - Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December - GlobeNewsWire